Prompt ophthalmology evaluation and immediate imatinib suspension should be suggested at any time of tyrosine kinase inhibitor therapy in patients with visual deficit, as it may be a clinical manifestation of optic disk edema, and suspension may help in prompt recovery.
Keywords: Adverse events; chronic myeloid leukemia; imatinib; optic disk edema; optic nerve edema; tyrosine kinase inhibitors.